Health Condition 1: null- Infants or children less than 5 years suffering from acute gastroenteritis Health Condition 2: A09- Infectious gastroenteritis and colitis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Merck Sharp and Dohme
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1. Child with age less then 5 years (less then 60 Months) 2. Suffering from acute gastroenteritis and attending outpatient clinic (Acute Gastroenteritis: three or more loose or watery stools in a 24-hour period and / or one or more episodes of forceful vomiting). These symptoms should have occurred within the previous 72 hours) 3. Parents willing to provide written informed consent
Exclusion criteria
Exclusion criteria: Exclusion Criteria: 1. Currently enrolled in another clinical trial 2. History of receipt of rotavirus vaccine / History of rotavirus infection in past 3. Any condition that in the opinion of investigator might interfere with evaluation of study objectives. 4. Parent / guardian unable to give consent and the required information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of rotavirus gastroenteritis among children with acute gastroenteritis attending private urban outpatient clinics in IndiaTimepoint: Enrolled infants/children would be followed up for 14 days after enrollmentgastroenteritis attending private urban outpatient clinics in India | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. percent distribution of rotavirus serotypes among rotavirus antigen-positive diarrheal stool samples. 2. Clinical presentation and severity of acute gastroenteritis 3. Impact of rotavirus and non rotavirus gastroenteritis on parents and family 4. Expenses incurred towards management of gastroenteritisTimepoint: Enrolled infants/children would be followed up for 14 days after enrollment | — |
Countries
India
Contacts
Public ContactDr Viraj Salgoankar
MSD Pharmaceuticals Private Limited
Outcome results
None listed